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Abstract
Background: Randomised controlled trials (RCTs) are the gold standard of evidence-based practice in medicine
but they have had limited influence in the field of intellectual disabilities. Previous literature suggests that
participants and professionals have limited tolerance for this type of research methodology. However, it is not
known how well service users, carers and other health professionals understand and accept the need for RCTs, and
why it is important for individuals with intellectual disabilities to be included in this kind of research.
Methods: We examined individual perceptions of RCTs in 51 participants (18 carers, 6 service users and 27
professionals) using semi-structured interviews. A framework approach was adopted in the analysis of data.
Results: We found that participants had concerns about capacity and resource allocation but held positive views
towards this type of research methodology. Understanding of the principles behind RCTs was poor amongst
service users and a minority of carers, but mediated by previous exposure to research for professionals.
Conclusions: The social validity of RCTs in intellectual disabilities may be compromised by lack of understanding
of the design and the on-going concerns about obtaining informed consent especially in incapacitated adults.
However, the overall finding that the need for this form of research was seen in a positive light suggests that there
is a turning point in the perceptions of stakeholders working in intellectual disabilities services. We recommend
that researchers include on-going education on RCT design during trials, tailoring it to all stakeholders with
emphasis on strong service user and care involvement. This could be a pivotal element in improving acceptability
of, and recruitment to RCTs.
Background
It is estimated that there are 187,000 adults known to
intellectual disability services in the UK [1]. Clinical
research with this population has historically been pro-
blematic as it raises severe and at times intractable ethi-
cal concerns [2,3]. Inexperience with clinical research
and randomised controlled trials (RCTs) in particular,
may hinder the development of effective interventions
for people with intellectual disabilities and mental disor-
ders and/or challenging behaviour.
RCTs that include individuals with learning disabilities
are rare, and only a small proportion of all papers pub-
lished in specialist journals for intellectual disabilities
concern RCTs [4-6]. The RCTs that have taken place
have been limited by under-recruitment [7-11] or high
drop-out rates [12]. Researchers have previously
reported numerous barriers to conducting RCTs that
include difficulties in communication, accessing partici-
pants through gatekeepers such as paid carers, lack of
understanding about clinical trial processes amongst
care agencies, and obtaining informed consent from ser-
vice users [13-15]. The latter is particularly important in
the UK in light of the Mental Capacity Act (2005) [16]
which not only presumes capacity from the outset but
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users to receive appropriate support in order to make
an informed decision.
There has been suggestion that stakeholders have lim-
ited tolerance for this kind of research and may be hos-
tile towards RCTs therefore decreasing the likelihood of
them participating in research trials [15,17]. In response
to this notion we reviewed the literature available on
participant experiences of RCTs [17] and found that sta-
keholders may be better able to understand the clinical
equipoise than was previously thought and that stake-
holder opinions may be changing. For example, parents
of children with autism involved in drug RCTs showed
that they had understood the various elements of a clin-
ical trial such as the use of placebo, the need to test the
medication efficacy, potential harm and benefits and the
right to withdraw at any time [18]. Another question-
naire survey reported high levels of satisfaction with the
practicalities relating to the use of drugs in autism and
the conduct of the trial [19-21]. Importantly, the level of
satisfaction reported was not related to participant’s
clinical outcome after the trial [21]. Furthermore, service
users with mild intellectual disabilities may have greater
understanding of RCT methods than might be expected
[22]. These examples illuminate a potential discrepancy
between carers and service users, and researchers who
believe that RCTs in this population are inherently
difficult.
Additionally, the Mental Capacity Act (2005) [16] pre-
sents a statutory framework which enables service users
the opportunity to be involved in research and sets out
the legal duties of researchers who wish to investigate
a n yv u l n e r a b l ep o p u l a t i o nw h om a yl a c kt h ea b i l i t yt o
make a voluntary, informed decision. In cases where ser-
vice users are deemed to lack capacity, ‘best practice’
states that proxy decision makers are essential, but that
any decision made on behalf of someone without capa-
city must reflect the best interests of the individual con-
cerned. The Act states that ‘informed’ consent should
be gained for any individual to participate in research.
Therefore service users and proxy decision makers
should have a richer understanding of RCTs than has
previously been assumed; else this would highlight an
ethical issue and a problem relating to the RCT recruit-
ment process.
It has been suggested that individuals are more likely
to participate in a trial if they deem the research as
being meaningful [21] but little work has been carried
out to explore the “social validity” [23] of RCTs in this
population. The concept of social validity originates in
Applied Behaviour Analysis and focuses on whether the
treatment goals of the intervention employed and the
outcomes achieved are acceptable, relevant, and useful
to the individual in treatment [19]. In order to enhance
ethical quality and future research activity, whilst
improving the evidence base for interventions for people
with intellectual disabilities, it is important to explore
stakeholders’ perceptions of RCTs and the procedures
that they may be asked to be involved in. Stakeholders
may include service users, paid carers, family carers and
professionals from health and social care background.
Using qualitative, semi-structured interviews we aimed
to investigate the opinions of stakeholders who were
involved in a recent pragmatic RCT in intellectual dis-
abilities concerning a psychological intervention for
challenging behaviour. Pragmatic RCTs evaluate the
comparative efficacy of two types of treatment in real
life settings, i.e. not under experimental conditions [24].
Furthermore, pragmatic trials require wide inclusion cri-
teria in order to gain resultst h a tc a nb eg e n e r a l i s e dt o
the wider population. This is therefore particularly use-
ful when including individuals with intellectual disabil-
ities in RCTs as the population of people labelled as
having intellectual disability includes a wide variety of
individuals, with and without additional diagnoses as
well as, a wide range of other individual differences.
Methods
Setting
The Randomised Evaluation of a Behaviour Intervention
for Learning Disabilities (REBILD) aimed to investigate
the clinical and cost effectiveness of a treatment model
for adults displaying challenging behaviour. Applied
Behavioural Analysis was delivered by a specialist team
in addition to treatment as usual (TAU), and TAU con-
sisted of assessment and management of service users
by a variety of professionals such as occupational thera-
pists, nurses or psychiatrists who populate community
based intellectual disabilities teams in the UK. Sixty-
three participants were recruited in total; thirty-two
were allocated to the treatment and TAU arm and
thirty-one to TAU. Details of the original clinical trial
have been reported elsewhere [25]. We asked stake-
holders including participants and professionals asso-
ciated with the RCT to take part in the present project.
Participants
We conducted semi-structured face to face qualitative
interviews with 51 participants: six service users with
mild intellectual disabilities who had adequate commu-
nication skills and were able to provide informed con-
sent, 11 paid carers, seven mothers (family carers) of
service users and 27 health and social care professionals.
The majority of the overall sample was female (75%).
Two of the service users who were interviewed for this
study had been randomised to TAU and four to the
treatment plus TAU arm. Eight family or paid carers
were part of a service user-carer dyad allocated to the
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vention group. Paid and family carers and service users
were sampled after the final follow up for the RCT at
six months. The interview timeframe was one day to
three months post trial bar one carer who was inter-
viewed after 10 months. Purposive sampling of health
and social care professionals aimed to achieve maximum
variation for the different professions within multi-disci-
plinary teams. We obtained a copy of the health and
social services register for staff working in local intellec-
tual disability services and recruited accordingly. The
professionals included nurses and social workers of var-
ious grades, psychologists, psychiatrists, occupational
therapists, speech and language therapists, and commu-
nity support workers. Further details about the socio-
demographic characteristics for all participants are given
in table 1.
Instruments
Interview schedules for the carers and professionals
were developed through reference to prior literature,
and piloted. Topics included in the interview schedules
related to research, RCTs, communication and informed
consent. Accessible versions of the service user interview
schedule and a vignette based on the REBILD trial were
developed with assistance from speech and language
therapists. Interview schedules consisted of open-ended
main questions and probes. Probes served two purposes;
firstly they enquired about areas of particular relevance.
Secondly, they served to remind participants of the
REBILD trial and elements therein should there be pro-
blems in recall. All interviews were audio taped except
for two where the service users preferred that written
notes be taken.
Ethics
Ethical approval was given by Essex 1 (formerly West
Essex) Research Ethics Committee prior to commencing
the research project.
Data Analysis
The audio taped interviews were transcribed verbatim
and then checked for accuracy. Identifying information
was removed to preserve anonymity and then transcripts
Table 1 Socio-demographic characteristics of participants
Professional
(n = 27)
Carer
(n = 18; paid = 11, family = 7)
Service User
(n = 6)
Total
(n = 51)
N (%)
Gender
Male 9 (33.3%) 1 (5.6%) 3 (50.0%) 13 (25.5%)
Female 18 (66.7%) 17 (94.4%) 3 (50.0%) 38 (74.5%)
Age group
22-25 0 (0.0%) 1 (5.6%) 0 (0.0%) 1 (2.0%)
26-30 3 (11.1%) 1 (5.6%) 3 (50.0%) 7 (13.7%)
31-40 5 (18.5%) 1 (5.6%) 3 (50.0%) 9 (17.6%)
41-50 7 (25.9%) 2 (11.1%) 0 (0.0%) 9 (17.6%)
51-60 10 (37.0%) 11 (61.1%) 0 (0.0%) 21 (41.2%)
61+ 2 (7.4%) 2 (11.1%) 0 (0.0%) 4 (7.8%)
Experience (years)
Mean = 17.6 yrs Mean = 13.4 yrs
1-5 4 (14.8%) 1 (5.6%) - -
6-10 5 (18.5%) 3 (16.7%) - -
11-20 6 (22.2%) 5 (27.8%) - -
21-30 7 (25.9%) 2 (11.1%) - -
31+ 4 (14.8%) 0 (0.00%) - -
--
Employment sector
Health care n=20 - - -
Nursing role 15 - - -
Psychiatrist 2 - - -
Psychologist 1 - - -
Speech therapist 1 - - -
Occupational therapist 1 - - -
Social Care n = 7 - - -
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gramme [26].
A “framework” approach was used to analyse the inter-
view data. It was coded through distinct coding rounds
with six transcripts coded per round. A code summary
was produced after each round. Similar codes were then
merged together producing a second code summary. The
summaries represented the first stage of framework
development. The approach followed the ‘Template Ana-
lysis’ by King [27]. After each coding round, and as new
data was analysed, networks of hierarchical relationships
between codes were created and refined. Data saturation
was estimated by counting the number of new codes and
categories generated after each coding round; this was
reached after the seventh round.
We ensured that the study complied with the four
components of study “trustworthiness": credibility, con-
firmability, transferability and dependability [28]. Cred-
ibility was addressed by summarising interviews to
interviewees and asking confirmatory questions. Con-
firmability was addressed by randomly selecting a sam-
ple of transcripts to be read by a second reader who
coded them using the framework developed by the first
reader. The two readers then discussed any differences.
This was carried out twice, after the second and final
coding rounds. The coding framework was revised until
it could account for the complete data set. Anomalous
data was identified during analysis. Transferability was
addressed by purposive sampling, and recording contex-
tual and demographic information. Dependability was
addressed by keeping a diary of events and recording
researcher perspectives. Analysis of pilot interviews
identified that a less structured, more responsive
approach was required and therefore methodology and
analysis strategies were reactive to study context.
Results
A number of common themes arose between the stake-
holders groups. There was a perception amongst carers
and professionals that insufficient financial resources
were available to optimally support this population.
However, despite this, views on research were almost
unanimously positive especially when the research was
designed to have a practical purpose. Professionals often
expressed the view that service users’ communication
skills and ability to provide informed consent made the
conduct of research ethically complicated. Below, we
report on the most common themes that arose from
each stakeholder group but a full list of all the themes
we encountered in the narratives can be seen in table 2.
1. Service users
Irrespective of group allocation, a minority of the inter-
viewed service users demonstrated some understanding
of basic concepts and at least one reported that trials
can be used to test the effectiveness of the service.
“[You’re doing this research] just to see how well the ser-
vice is run from a scale of one to ten” (Service user #6)
“Research is finding out stuff” (Service user #3)
Most service users focused on the fact that research
required to “ask for people’so p i n i o n s “. Only one service
user appeared unable to explain what research was in any
way, describing it as “something that gets you around“.
Service users were aware of the importance of com-
munication skills in relation to their daily lives. One ser-
vice user indicated that people with intellectual
disability can develop complex skills, such as sign lan-
guage, in order to compensate for communication defi-
cits. They suggested the use of pictorial information to
aid understanding.
“Ac o u p l eo fm yf r i e n d sa r eD o w n ’sa n dt h e yc a nu s e
sign language, they can lip-read as well. There’s two of
them, they’re both very good at signs, very good. It’sn o t
easy to do or understand, I can’td oi t .S o m ep e o p l ew i t h
learning disabilities can be very good at signs; it depends
o nh o wy o u rb r a i nw o r k s . ” (Service user #1)
“Using pictures might help” (Service user #1)
One service user was particularly positive about
research and described it as a platform by which they
Table 2 Emerging themes and frequency per participant
group
Theme Service
Users
Carers Professionals Total
Safeguarding 1 1 17 19
Motivation 3 14 3 20
Disadvantage/labelling 3 6 12 21
Fairness 5 16 13 34
Access 4 9 24 37
Funding/resources 2 13 23 38
Seeking help and support 4 16 19 39
Research outcomes 3 15 23 41
Research within services 1 15 27 43
Communication/understanding 5 13 25 43
Preferences 3 15 25 43
Perception of clinical research 4 16 24 44
Method 5 14 27 46
Informed consent 5 16 26 47
Benefits 5 16 27 48
The work environment 3 18 27 48
Terminology 5 17 26 49
Approach 5 18 27 50
Opinions about research 6 18 27 51
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finding out about the outcomes of the research.
“I think research is good because you get input off
everyone else who...you have input in the fact that
you can get your point across...to the researcher, then
they can do the research on any information at the
end of it, it’s really quite a good input. You feel like
you’re giving something to the researcher.” (Service
user #5)
“I’d like to know where does this go, what becomes of
this when it is completed. I just wondered really.”
(Service user #6)
Procedures such as chance allocation and comparison
groups appeared to cause two service users worry about
the ‘fairness’ of a procedure in which some participants
were seen by a service before others.
“Id o n ’t think it should be chosen by a computer I
think people should actually go through more...who
needs the help the most and then put them at the
top. [...] I think everyone should really get the help, I
don’t think you know, otherwise it isn’tf a i r . ” (Service
user #3)
“Six months is too long to wait for help. Within that
time, those other ten that didn’t get the help six
months before were now probably...in and out of hos-
pital, lost, don’t know where they’re going.” (Service
user #5)
“It really depends on if they see one party before the
other, because it could be unfair to do the other peo-
ple if they didn’t get that treatment. That’sj u s tm y
opinion. I think everyone has got the right to equal
opportunities and get services.” (Service user #6)
One service user associated the allocation of partici-
pants to the treatment and TAU groups to the lack of
resources in the local area, which was a perception
shared across the participant groups.
“It h i n ki t ’sb e c a u s et h e r ei s n ’t enough nurses out
there...there isn’t enough nurses, there isn’t enough...
help groups, there isn’t...to manage, there’sal o to f
patients out there that need help.” (Service user #5)
2. Family carers
As with the service users, family carers were positive
about research irrespective of the trial arm the service
user was assigned to. There was greater emphasis on
how the research would be followed up with practical
action and dissemination.
“It h i n ki t ’s a good idea, it depends if it’sj u s t
research or if they’re actually gonna do something
with it” (Family carer #3)
“It would be nicer to sort of, so that that you knew
exactly the end result, what was actually going on
with the research.” (Family carer #5)
“If we didn’t have research we wouldn’t be where we
were today would we? [...] if research wasn’t done the
scientists and things didn’td ow h a tt h e y ’ve gotta do
we’d never...go out...you know get further on in medi-
cine and whatever.” (Family carer #6)
Family carers appeared to have a varied understanding
of the trial procedures and were concerned that it might
prevent access to services that they needed. Those who
did not understand the trial procedure were unsure
about why their relative had been allocated into the TAU
group. However, one carer was able to describe the need
for comparison groups in order to evaluate the service.
“Otherwise what have you got to compare it with? You’ve
got no comparison. If everyone gets the same...service, if
everyone got say both, if everyone just got the behaviour
therapy service, then what have you got to compare it
against? You’ve got nothing.” (Family carer #2)
“It seems very random to pick them by computer as
to say one...Group 1 or Group 2. I don’t quite see the
point of it [...] I don’t understand. Why do they have
two groups? I mean why are they not all assessed the
same?” (Family carer #1)
“Id i d n ’tu n d e r s t a n dw h a ti tm e a n t ,It h o u g h tt h a t
once [the nurse] had put her information over to
them that they would automatically get involved
with X...and it didn’t work out that way in the end.”
(Family carer #4)
The family carers were aware of the process of
informed consent and questioned how the service users’
communication problems might impact on that process.
Mostly they felt it was natural to provide permission to
participate on behalf of someone who lacked capacity.
However, one family carer reported discomfort in taking
responsibility for agreeing on behalf of a relative; she
argued that her views were only one of many including
other stakeholders (e.g. professionals) whose input was
equally valid, but might contradict her own views.
“We are and were his consent on this, but we knew
that it was for his good, and that why we at the...but
whether it was the behaviour therapy, whether it was
the community learning, that meant no difference to
X...himself, it wouldn’t have mattered whether it was
the Pope.” (Family carer #2)
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again it’sav e r y ,v e r ys t i c k ya n dav e r ya w k w a r d
situation. I think you’ve got to have an input from
everybody, psychiatrists, doctors, consultants but I do
feel the perhaps 60-70% of the results should come
through the carers.” (Family carer #5)
3. Paid carers
Paid carers thought of research as important for the
improvement of future service delivery.
“If you don’t do research how are you going to learn?
And make it better for the next lot that come along”
(Residential care manager #1)
“Without research you’re not finding out new infor-
mation and you can’t make your way forward can
you?” (Paid carer #1)
“I have a positive attitude towards research on people
with learning disabilities because I read a book
where there were very many positive examples of how
the research changed the work practice for the better
of this client group.” (Paid carer #2)
Paid carers had better understanding of the trial than
family carers and service users. Several were aware of
the use of placebo as control in drug trials, that usually
there is a comparison group and, within this context,
our trial procedures were seen as acceptable. More than
family carers, some paid carers expressed doubt whether
quantitative measurements used within RCTs including
REBILD were subtle enough to measure the complex
nature of each service user’s difficulties.
“How else would you do it?...Because you’ve got to
get...a different perspective haven’t you? For the group
that has been helped and the group that hasn’t, it’sa
bit like taking a placebo innit?” (Residential care
manager #2)
“As I say the questionnaires they’re very good but
they’re questionnaires and questionnaires are never,
never accurate because you can only say ‘yes’, ‘no’,
‘maybe’, ‘sometimes’.” (Paid carer #3)
However, two paid carers criticized the research pro-
cess. For example, for one of the carers assessments car-
ried out by the researcher were seen as potentially
influencing the service user’s allocation to the treatment
group while the other likened the trial procedure to a
lottery.
“My understanding was that you came here, took back
as much details about the incident of the concerns we
h a dw i t hX ,t h e ny o uw o u l dt h e nf e e di tb a c kt ot h e
main core, the main centre then it was from that that
they would decide whether the input or who would be
selected.” (Residential care manager #3)
“I really don’tk n o w ,I ’ve no idea...it’s like picking
your numbers out of the lottery...and, it’sj u s tn o t
right.” (Paid carer #3)
A foremost concern for the paid carers was the way in
which consent was gained to enter a service user with-
out capacity into a trial; paid carers liked a shared deci-
sion to be reached for those individuals. Subsequently,
paid carers often believed that a decision should be
made in the best interest of the service user.
“I think the whole team, if the person with the learn-
ing disability doesn’t understand or won’t agree, the
whole team have to get together and find out, you
know how we’re gonna work around it.” (Day services
manager #1)
“I think a good consent procedure would be the key
people working with the client himself or their selves,
the people that are important to the client in their
lives, and I think they are the best people to be able
to make that decision but I don’tm e a nd o c t o r s ,c o n -
sultants and people like that who only sort of see
them for maybe 10 minutes, 15 minutes in a month.”
(Residential care manager #3)
4. Professionals
This group recognised that the area of intellectual dis-
abilities was lacking in evidence based care that would
be important for the development of treatments in this
field. The professionals felt that evaluation of services
was urgently needed, and in their interviews they tended
to focus upon research outcomes rather than research
process. As a group, they thought that it was important
to disseminate research and to learn from it.
“It’s a very important area for the obvious reasons
that learning disabilities services have progressed so
much in the last twenty to thirty years that...and
again there has been very little research apart from
in very key areas.” (Nurse #1)
“Y e a hIm e a na sl o n ga si ti s n ’t...research for the sake of
research, if there’s a goal and it’s gonna move the ser-
vice on, fine, you know.” (Social care professional #1)
“The main one [aim] is to do the research to see in
what way we can improve the service and if possible
get that published so that would disseminate the
findings to other professionals.” (Nurse #2)
Compared to the other stakeholders, professionals
showed the greatest knowledge and understanding of
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ate a treatment or service). Some professionals, particu-
larly psychiatrists, were enthused about the clinical trial
and considered randomisation as an essential compo-
nent in increasing the reliability of the results.
“Well there’s nothing to think about, randomised con-
trolled trials are important, important to find out
and...how effective the treatment that is helping peo-
ple.” (Psychiatrist #1)
“I quite understand that without doing it, we
wouldn’t know the result. It’s one of those things that
I believe has to be done in order to get some answers”
(Nurse #1)
Other professionals agreed with the value and need for
the trial but felt frustrated because their preference
would have been for the service users to access such a
highly regarded service as quickly as possible. The big-
gest problem identified was the perceived interference
with referrals to the specialist service as a result of the
trial which led to participants expressing dissatisfaction
with the project. At times, the trial was viewed nega-
tively because of this. However, there was an accepted
six month waiting list at the time that the trial com-
menced.
“By randomising the cases, it’s stopping us from using
the service that we really badly need, because we’re
not just referring for the sake of referring, we’ve tried
everything we can.” (Nurse #4)
“You need a control group for comparing it against
and the only fair way of doing that is to randomise
it...But yeah it has just been frustrating with lots of
our clients being under the control group.” (Profes-
sional therapist #3)
Professionals also expressed doubt about whether ser-
vice users would understand the complexities of the trial.
“Id o n ’t think a lot of our clients could ever under-
stand the implications of something like this.” (Nurse
#5)
“It has always been a difficult field because you do
not have a subjective view of the service user [...] I
find it quite difficult to undertake research especially
where the service users are...involved.” (Nurse #6)
As a group they also thought that multidisciplinary
consent from various sources was necessary in order for
service users to take part in the trial.
“It’s obviously a complex matter, however I feel that
a multi-disciplinary type of community or team to
offer consent in those cases, appropriate in people
from professions, their family and as well as advo-
cacy service.” (Psychiatrist #1)
“We need to have a multi-disciplinary team meeting
to see whether it is for the benefit or for the goodness
of the client. In other words you can get the consent
from the multi-disciplinary team on behalf of the cli-
ents.” (Nurse #3)
Discussion
Main findings
The majority of stakeholders viewed the methods under-
pinning RCTs and the need to conduct such research in
a positive light. Therefore, the social validity of such
research appears to have improved considerably in
recent years compared with previous reports.
RCT procedures were seen in a mixed light. Firstly, it
is important to note that trial procedures such as ran-
dom allocation were poorly understood within the ser-
vice user and family carer groups. Clinical training and
experience unsurprisingly appeared to affect understand-
ing in a positive way. Acceptance of the trial in profes-
sional and paid carer groups therefore appeared to be
influenced by their acceptance of research outcomes,
and of the perceived need to engage in research.
When prompted, some of the service users inter-
viewed wondered about the fairness of random alloca-
tion to the two groups. Similarly, family carers were
concerned about what the individual service user stood
to gain from the research. For professionals, the empha-
sis was often on improving services or at least not com-
promising current care. They expressed positive views
about the trial as long as it could help to make progress
in the long term; however, negative opinions appeared
to be associated with an anxiety about trials being a
door to diverting resources away from highly prized ser-
vices. A practical consideration for stakeholders, as
expressed by some professionals, was of barriers to
accessing specialist treatment and their frequently
expressed preference for the Specialist Behaviour Service
over TAU; they had preferences for a new treatment
over an old one. This contradicts the idea of clinical
equipoise, where a clinical community is uncertain
about whether one treatment is more effective than
another, and there is insubstantial evidence to suggest
that one treatment is superior. In this context however,
participants might benefit from accessing treatments
that would otherwise be unavailable to them because of
the scarcity of resources and the length of waiting lists,
at least half of the time.
Carers and professionals expressed significant worries
about obtaining valid consent and the ethics of deciding
on someone else’s behalf. Most professionals and one
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meet to discuss participation in RCTs or research in
general and whether this was in the service user’sb e s t
interests.
Strengths and weaknesses
This is the first qualitative study to explore the views of
a diverse range of individuals who have participated in a
pragmatic RCT that involved people with intellectual
disabilities. The stakeholders came from a wide range of
settings and socio-demographic backgrounds across the
intellectual disability community. The qualitative analy-
sis strategy led to a more detailed description of context
and a greater degree of flexibility in interpreting the
data. The setting was similar to that of community intel-
lectual disabilities services across the UK. Although it
can be argued that the results reflect a local situation,
the concerns and opinions expressed are by no means
restricted to the service users with intellectual disabil-
ities but are widespread across other populations and
interventions. We would have liked to have recruited
more service users but the condition that individuals
had to have taken part in the REBILD study and have
sufficient communication abilities to be interviewed,
limited the number of service users that were eligible.
As it is, 30% of all those eligible agreed to be inter-
viewed. It would have been of particular interest to
include those who had opted out of the RCT trial as it
is possible that individuals who do not wish to enrol in
RCTs might differ in their attitudes towards RCTs.
However, there were only six individuals who declined
to take part when first approached, therefore, we do not
believe that our findings would be drastically altered.
Furthermore, this particular RCT recruited people with
intellectual disabilities and challenging behaviour, which
m e a n tt h a tt h es e r v i c eu s e r sm a yh a v eb e e nm o r ed i f f i -
cult to work with than average, and the carers and pro-
fessionals more desperate for help.
Results in context
M a n ys t u d i e sh a v ef o c u s e do nt h et e n d e n c yf o rp a t i e n t
and carer participants to misunderstand the methodolo-
gical rationale behind an RCT. This has resulted in an
extensive discourse about the concept of therapeutic
misconceptions [29]. It suggests that RCT participants
continue to believe that the treatment will be provided
in accordance with their needs. In doing so, they fail to
understand the implications of random allocation. It is
suggested that increased understanding of trial concepts
may lead to greater satisfaction with RCTs [30], which
in turn is likely to increase participation in and engage-
ment with trials.
Prior surveys of carers of people with intellectual dis-
abilities sought to explore participants’ satisfaction with
RCTs [19-21] in order to demonstrate the acceptance or
social validity of these types of trials. Similar to our
study, researchers stated that carers were satisfied with
and supportive of RCTs. However, these studies related
solely to pharmacological clinical trials and not to psy-
chological interventions. They also relied on quantitative
multiple-choice format rather than in-depth interviews
that explored the opinions of stakeholders towards the
trial. Given the limited number of RCTs in the field of
intellectual disabilities, our study not only adds to the
previous body of work, but updates the often held belief
that stakeholders are negative towards research in gen-
eral and RCTs in particular in intellectual disabilities.
Recruitment is a recognised problem in many RCTs.
Recent data suggest that out of 114 UK trials funded by
the Medical Research Council and the Health Technol-
ogy Assessment programme only 31% recruited success-
fully, 45% recruited less than 80% intended, and more
than half required an extension [31].
A systematic review [32] of barriers to recruiting parti-
c i p a n t si n t oR C T si no t h e rf i elds reported similar con-
cerns to those in our study. Examples are individual
preferences to be allocated to the intervention over the
control group, uncertainty about the outcome of the
intervention, and concern about the process of obtaining
informed consent. Elsewhere, it has been noted that
members of the public would be more likely to enter
RCTs for reasons of self-interest rather than altruism
[33]. Individuals in this study showed preference for the
intervention group suggesting that they were hoping to
experience direct therapeutic benefit from the novel
intervention and therefore, the present findings echo
this previously noted observation.
Meaning of the study
It appears that the increasing acceptability of RCTs is not
merely dependent on the type of interventions, e.g. drugs
vs. psychological therapies, but may herald a change in
how practice and outcomes are currently regarded within
the clinical and research community in intellectual dis-
abilities. Despite full recruitment to the REBILD trial, low
numbers of RCTs that include people with intellectual
disabilities suggest that recruitment rates may be more
atypical than the general population (personal communi-
cation to AH by Anna Cooper, 2010). In addition, the
majority of service users with intellectual disabilities fail
to fully understand the rationale behind an RCT. Detailed
understanding of research methods by carers and profes-
sionals should not be assumed either and therefore it is
imperative that researchers seek innovative and accessi-
ble ways in which to familiarise stakeholders with the
RCT design concepts.
Our findings suggest several topics that researchers
should address before they start a trial. For example,
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carers it is important to consider how the study will
affect participants personally, during and after the
research, and how the activity will translate into practi-
cal outcomes. Additionally, when discussing a study
with professionals, researchers should emphasise how
the work will fit alongside existing patterns of service
delivery and how it may advance local strategies for
future service development. Furthermore, including ser-
vice users in active roles as co-researchers or consul-
tants during the design process has been found to
improve research relevance, recruitment and dissemina-
tion [34,35]. This has been carried out in the field of
intellectual disabilities research [e.g. 36-37]. Therefore,
information sheets can be developed and presented in a
way that makes the most sense to the service user [38]
and studies show that they aid in obtaining informed
consent [34]. Different types of communication aids for
people with intellectual disabilities, such as Talking
Mats, may assist in the service user expressing him/her-
self more freely, thus, overcoming communication
challenges.
A report for the Service Delivery and Organisation
programme stated that people with intellectual disabil-
ities would like to take a bigger role in research [39] but
little has been done in this respect regarding RCTs.
Inclusive research can increase ethical quality and make
research more understandable and relevant to the peo-
p l et h a ti tu l t i m a t e l ya f f e c ts and therefore this is one
possible option for improving research in this area in
the future.
Conclusion
Our findings are in contrast to previous research [15]
which argued that stakeholders in intellectual disabilities
services were hostile towards or put up barriers to the
conduct of RCTs in this population group. This is a
new perspective that has implications for researchers in
overcoming difficulties which include making research
related information more accessible, understandable,
and meaningful. We encourage researchers to consider
all options to engage with the stakeholders and to evalu-
ate these options given the widespread issues of poor
recruitment and understanding of clinical trial metho-
dology. The benefits of participation in research,
although not immediately accrued, are significant given
the widely acknowledged health and social inequalities
that people with intellectual disabilities experience.
Therefore it is timely to abandon long held views within
the scientific community about stakeholder opposition
to RCTs and ensure that the care people with intellec-
tual disabilities receive is based on the best evidence
available.
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